Tag: Alzheimers
The FDA Should Grant Emergency Use Authorization for Alzheimer’s Drug
In March 2019, an experimental drug designed to treat Alzheimer’s disease named aducanumab failed a futility test during the process for approval from the Food and Drug Administration. Facing seemingly little hope for success, aducanumab’s producers Biogen and Eisai strongly considered abandoning the project. However, when the drugmakers conducted further analysis on a larger...
Read More »
Promising Alzheimer’s Drug on FDA Fast Track
Well before Covid-19 emerged, medical researchers warned that the rapid increase of Alzheimer’s disease in older populations would lead to the next “pandemic.” In many respects, they were right. According to the Alzheimer’s Association, nearly 10 percent of the U.S. population over 65 years old suffers from that progressively destructive brain disorder. The same...
Read More »
Robert Klein, Davy Crockett, and the Quest for Another $5.5 Billion for Stem Cells
As this column has often noted, the 2004 ballot measure Proposition 71, the $3 billion California Stem Cell Research and Cures Act, promised life-saving cures for Alzheimer’s, Parkinson’s and other diseases, plus a steady stream of royalties for state coffers. In 2020, a ballpark estimate for the promised cures and therapies is zero, and...
Read More »
Breakthrough Alzheimer’s Drug Puts FDA’s Drug-Approval Process into Question
After many successful years as a corporate manager, Roger retired in his late sixties to spend more time with family. Three years into retirement, his once energetic and outgoing demeanor deteriorated, and he no longer found interest in things he once enjoyed. Concerned, his physician referred him to a psychiatrist. During his evaluation, Roger...
Read More »
  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org